Cisplatin
Potent platinum-based antineoplastic agent. Anticancer compound. Forms inter- and intrastrand DNA adducts/crosslinks, consequently blocking DNA replication and transcription and inducing cell death. Nephrotoxic when used in vivo. Potent chemoimmunotherapeutic. Stimulates the immune responses by activating macrophages and other cells of the immune system. Apoptosis inducer via p53-dependent and -independent mechanisms. Induces apoptosis through caspase-3 activation and XIAP expression inhibition. Targets other proteins and enzymes. Non-competitive NHE-1 inhibitor, an archetypal, membrane-bound mechanosensitive sodium-hydrogen ion transporter.
Catalog Number | AG-CR1-3590-M250 |
Alternative Name(s) | cis-Diamminedichloroplatinum (II); cis-DDP; CDDP; NK 801; NSC119875; TR170; Neoplatin |
Research Area | Apoptosis, Biochemicals, Cancer, Cell Death |
Molecular Formula | Cl2H6N2Pt |
CAS# | 15663-27-1 |
Purity | >98% |
Inchi | InChI=1S/2ClH.2H3N.Pt/h2*1H;2*1H3;/q;;;;+2/p-2 |
Inchi Key | LXZZYRPGZAFOLE-UHFFFAOYSA-L |
SMILES | N[Pt](N)(Cl)Cl |
Size | 250 mg |
Supplier Page | http://www.adipogen.com/ag-cr1-3590/cisplatin.html |